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List of Abbreviations 
acyl-CoA acyl-coenzyme A 
AP-1 activator protein 1 
ASK1 apoptosis signal-regulating kinase 1 
ATF‑4 activating transcription factor 4 
ATF-6 activating transcription factor 6 
BAK Bcl-2 homologous antagonist/killer 
BAX Bcl-2 associated X 
Bcl-2 B-cell lymphoma 2 
BiP/GRP78 binding immunoglobulin protein/glucose-regulated protein 78 
cDNA complementary DNA 
CHOP C/EBP homologous protein 
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ER endoplasmic reticulum 
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FA fatty acid 
FAT/CD36 fatty acid translocase/ cluster of differentiation 36 
FFA free fatty acid 
GAPDH glyceraldehyde 3-phosphate dehydrogenase 
GC-FID gas chromatography coupled to flame ionization detector 
IKK inhibitory-κB-kinase 
IL-1R interleukin 1 receptor 
IL-1β interleukin 1β 
IL-6R interleukin 6 receptor 
IRE-1α inositol-requiring enzyme 1α 
JNK c-Jun aminoterminal kinase 
LC-MS/MS Liquid chromatography–mass spectrometry/mass spectrometry 
mRNA messenger ribonucleic acid 
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 




NF-κB nuclear factor-κB 
PDI protein disulfide isomerase 
P-eIF2α phosphorylated eukaryotic initiation factor 2α 
PERK protein kinase R-like ER kinase 
P-JNK phosphorylated c-Jun aminoterminal kinase 
PKC protein kinase C 
PKR protein kinase R 
PLC phospholipase C 
PS phosphatidylserine 
RINm5F rat insulinoma cell line 
RNase ribonuclease 
ROS reactive oxygen species 
S1P site-1 protease 
S2P site-2 protease 
SAPK stress activated protein kinase 
Ser-Thr serine-threonine 
sXBP-1 spliced X box-binding protein-1 
TFA trans-fatty acid 
TG triglyceride 
TLR-4 Toll-like receptor-4 
TNF-α tumor necrosis factor-α 
TXNIP thioredoxin interacting protein 
UPR unfolded protein response 
uXBP-1 unspliced X box-binding protein-1 
VLDL very low density lipoprotein 





1.1. Obesity and diabetes 
Non-esterified or free fatty acids (FFA) are excellent nutrients for most aerobic 
cells of the organism. They are produced in the adipocytes by the hydrolysis of storage 
triglycerides in starvation, and secreted in the blood plasma where they are mostly 
associated to albumin [1]. The fatty acid (FA) molecules entering the cytosol are readily 
conjugated with Coenzyme A. This reaction serves both activation and an entrapment of 
FAs in the cell [2]. Fatty acyl-coenzyme A (acyl-CoA) is a central intermediate in lipid 
metabolism, as it can be transported into the mitochondrial matrix or peroxisome for 
β-oxidation, it can be elongated and/or desaturated in the endoplasmic reticulum (ER) 
membrane, and it can be inserted into complex lipids, such as di- and triglycerides (DGs 
and TGs), phosphoglycerolipids, ceramides and other sphingolipids or cholesteryl esters. 
Generally, a permanent increase in the FFA levels can be linked to obesity, one of 
the most concerning problems of the modern world, which is largely caused by the so 
called “western-type” diet, as well as the lack of exercise. Metabolic and hormonal 
changes in a sustained overnutrition favor adipocyte hypertrophy in the human body [3]. 
The FAs originated from food are absorbed in the intestines as resynthesized complex 
lipids, mostly triglycerides packed in chylomicrons. They can reach from the intestinal 
lymphatics through the systemic blood circulation directly to the fat tissue. Amino acids 
and monosaccharides from digested food reach the liver through the portal system, where 
a large portion of them is converted to FAs and incorporated in TGs. These TGs are also 
transported to the fat tissue packed in very low density lipoprotein (VLDL), through the 
systemic circulation. The esterified FAs transported in lipoproteins, either chylomicrons 
or VLDL can enter the adipocytes, after getting liberated with the help of lipoprotein 
lipase [4]. The excess nutrients, which are accumulated because of an overfeeding for an 
extended period of time, are a heavy burden on the adipose tissue. Due to the limited 
number of adipocytes, excessive fat deposition causes adipocyte hypertrophy, which may 
lead to a local inflammation. The amount and activity of macrophages and lymphocytes 
increase, which is caused by the secretion of adipokines (e. g. tumor necrosis factor-α; 
TNF-α) and leukotrienes from the swollen cells. Stimulated inflammatory macrophages 
secrete cytokines, such as TNF-α and interleukin-1β (IL-1β), which disturb the local 




driven TG mobilization combined with TG deposition maintained by the oversupply of 
nutrients, result in an accelerated TG turnover, which in turn increases the FFA release 
of the tissue. Ultimately, the local inflammation in the adipose tissue is spread by elevated 
plasma FFA and cytokine levels to the whole body. The excessive and sustained supply 
of FFA not only disrupts the function of the most important metabolic tissues (liver, 
muscle), but damages the β-cells too. It causes insulin resistance, which leads to higher 
blood sugar levels and an intensified insulin demand but it also hinders the compensatory 
insulin synthesis, and it can even decrease insulin levels through reducing the β-cell mass 
[6]. This process called lipotoxicity is widely regarded as a key link between overweight 
and type 2 diabetes [5]. The complex intracellular mechanism of lipotoxicity has been 
intensely investigated in various cell cultures, including diverse insulinoma cell lines, by 
using high concentrations of palmitate (16:0) and oleate (18:1 cis-Δ9), i.e., the major 
endogenous saturated and mono-unsaturated FAs, respectively.  
1.2. Molecular background of the toxicity of fatty acids 
Elevated plasma FFA levels can disturb the function of the cells since they are 
both signal and nutrient molecules. They can exert their toxic effect on the cell in several 
ways. Connecting to the Toll-like receptor-4 (TLR-4), interleukin receptors (IL-1R, IL-
6R) and tumor necrosis factor receptor, all of which can be found on the outer surface of 
the plasma membrane, they can initiate signaling pathways related to inflammation [7]. 
These pathways meet at the activation of two major serine-threonine (Ser-Thr) kinases, 
i.e., the inhibitory-κB-kinase (IKK) complex and the c-Jun aminoterminal kinase (JNK). 
Both of these kinases contribute to the inflammatory cell response on the level of the 
genes, through nuclear factor-κB (NF-κB) and activator protein 1 (AP-1) transcription 
factors [5]. They contribute to the development of insulin resistance and the activation of 
JNK can also induce apoptosis. It is important to emphasize, that JNK phosphorylation is 
not specific to inflammation, rather it is a general stress activated protein kinase (a.k.a. 
SAPK) [5, 8]. The cell does not regulate, or only to a limited amount, the uptake of FAs, 
so the FFA consumption is proportional in a wide range to the supply. The entry of FAs 
into the cell can happen in two ways, with passive diffusion through the double layered 
plasma membrane and with facilitated membrane protein transport [9]. Among several 




of the type B scavenger receptor family. This protein works also as a receptor, whose 
stimulation turns on the phospholipase C (PLC) signaling pathway [10]. Extended stimuli 
can keep a constant level of the different activated protein kinase C (PKC) isoforms, and 
it can also lead to Ca2+ depletion in the ER [11]. The consumed FAs are converted to acyl-
CoA by acyl-CoA synthetase and enter different catabolic and anabolic pathways.  
Oxidative degradation of FAs takes place in the mitochondria and peroxisomes. 
The FA oversupply causes an increased oxidation, which inevitably amplifies the 
generation of the reactive oxygen species (ROS) and the resulting oxidative stress is an 
additional effective activator of IKK and JNK [5]. Besides this, the shift in the redox 
equilibrium impairs the function of the ER. There is no other effective process of FA 
degradation apart from β-oxidation, which can decrease the increased acyl-CoA supply, 
therefore in case of lipotoxicity, when β-oxidation is saturated, the acyl-CoA dependent 
lipid synthesis also intensifies. To store the FAs, the optimal anabolic pathway is the TG 
synthesis [4]. Unfortunately, this process cannot be considered as physiological in case 
of most cell types, thus its capacity is often limited. The synthetized TG is neutral, 
hydrophobic, which needs to be stored in the cytoplasm in the form of lipid droplets. This 
ectopic lipid deposition is an essential part of lipotoxicity and formerly it was considered 
as the main reason for cellular damage. Nevertheless, it is possible that the formation of 
lipid droplets is the least harmful way to relieve the cells from the noxious acyl-CoA 
oversupply. Therefore, the steatosis can be considered as a self-defense strategy of the 
cells, rather than a mechanism of lipotoxicity [4]. FAs can also be used in the synthesis 
of a wide variety of membrane lipids, but these cannot be accumulated by the cells.  
1.2.1. Diglycerides 
DGs have a glycerol backbone and two of its hydroxyl groups are connected with 
two fatty acyl groups through ester bonds. These molecules can function as precursors in 
the synthesis of TGs and other complex lipids (e.g. phosphatidylserine (PS), 
galactolipids). DGs are important intermediates of phospholipid metabolism, so 
alterations in their structure can have a major effect on the structure and fluidity of the 
membrane lipids as well [4]. DGs, as major lipid species have signaling functions since 
their accumulation results in the activation of the PKC isoforms [12] and the role of some 




least, in case of elevated FA levels, DGs also have a negative effect on the insulin 
secretion of β-cells [13]. 
1.2.2. Ceramides 
The forced stimulation of the synthesis of sphingolipids in lipotoxicity is 
particularly interesting and results in the accumulation of ceramides. These molecules are 
amides of a sphingosine molecule and a FA chain. They compose the hydrophobic central 
part of many different sphingolipids and also have an important role as signal molecules. 
Ceramides affect cell growth, proliferation and the aging of cells, and they also influence 
the induction of apoptosis  [14-17]. The role of ceramides in lipotoxicity, and within that, 
their role specifically in β-cell death is demonstrated and discussed in several studies [18, 
19]. Many publications also suggested they have a role in the development in insulin 
related diseases, such as non-alcoholic fatty liver disease (NAFLD), insulin resistance 
and in β-cell failure, thus they are important in type 2 diabetes [20-23]. It was also proved 
that the cytotoxic effect of two major inflammatory cytokines (TNF-α and IL-1β) is at 
least partly mediated through an increased ceramide production [24, 25]. Fatty acyl-CoA 
surplus intensifies the intracellular de novo synthesis of ceramides, which are 
intermediates in the formation of membrane sphingolipids. The sphingolipids, by their 
nature, cannot be accumulated in the cells and the product of their hydrolytic degradation 
is sphingosine. During the salvage pathway, this compound is acylated to form ceramides 
again. Fatty acyl-CoA enters into the ceramide synthesis at more than one point, so it is 
evident that the oversupply of fatty acyl-CoA can increase the ceramides levels in the 
cells. The adverse effect of ceramides is caused partly due to their role in the induction of 
ER stress and partly due to their direct stimulatory influence on apoptosis [18, 19]. As it 
has been shown, the mechanism of lipotoxicity is converging to the dysfunction of the 
ER, so it is not surprising that the ER stress is the central factor of lipotoxicity and its 
associated adverse conditions. 
1.3. The endoplasmic reticulum stress 
The ER is an important center of protein synthesis and maturation and, 
cooperating with the Golgi apparatus, takes part in the sorting of mature proteins. The ER 
also has a role in the adaptation of the cells to environmental changes, so it is essential in 




by a regulatory mechanism known as the unfolded protein response (UPR) [26]. The UPR 
is activated when the amount of misfolded proteins raises, which can be caused by several 
reasons. These are, for example, synthesis of mutant proteins or disturbance in the protein 
processing, but the UPR can also be activated by changes in the Ca2+ levels, by glucose 
or energy deficit, hypoxia, high acyl-CoA and ceramide concentrations or by different 
toxins [5, 27]. The UPR is initiated by three ER stress sensor proteins and these are the 
protein kinase R (PKR)-like ER kinase (PERK), the inositol-requiring enzyme 1α (IRE-
1α) and the activating transcription factor 6 (ATF-6) [26]. All three of the mentioned 
proteins have ER-luminal domains, which enables them to detect the amount of misfolded 
proteins, directly or indirectly. In case the amount of unfolded proteins reaches critical 
levels, they activate different intracellular signaling pathways. The dimerization or 
oligomerization of IRE-1α or PERK is inhibited by an ER chaperon, the binding 
immunoglobulin protein (BiP or GRP78), in normal cells. In case of stress, the 
termination of inhibition happens, because the BiP protein binds to the misfolded proteins 
with greater affinity [28]. In addition, the misfolded proteins also bind to the luminal 
domain of IRE-1α and PERK as activators [29, 30]. In any case, the primary goal of the 
cell is to restore the protein synthesis and maturation processes and to survive [31]. The 
pathways of the ER stress response are tightly coupled to each other, and the hallmarks 
of the complex process can be considered as either early or late ER stress markers. Early 
ER stress markers are those which appear almost immediately after the stress forms, for 
example modification of X box-binding protein-1 (XBP-1) mRNA and translation of 
XBP-1, as well as the phosphorylation of eukaryotic initiation factor 2α (eIF2α) and JNK, 
although, as it has been mentioned above, the latter cannot be considered to be ER stress 
specific. Late ER stress markers are the ones, whose development requires longer 
stimulation, and thus occur in a prolonged stress such as the induction BiP and protein 





Figure 1. Cellular effects of free fatty acids. FFAs bind to the cell surface receptors or 
get metabolized through binding to CoA, after entering into the cells. The membrane 
receptors stimulate pathways, which activate IKK and JNK kinases and this leads to 
inflammation. The elevated level of fatty acyl-CoA increases the amount of DGs, TGs 
and ceramides. Because of the enhanced mitochondrial FA oxidation, the amount of ROS 
increases. The increased fatty acyl-CoA concentration induces ER stress directly and 
indirectly, via ceramides and ROS as well. During ER stress, different transcription 
factors, like XBP-1, ATF-4 and ATF-6 and chaperons, like BiP and PDI are activated 
and/or induced. The ceramides have an effect directly and via ER stress on the 
phosphorylation of eIF2α and JNK, and also activate the CHOP transcription factor. 
These changes can lead to activation of the effector caspase-3 and start the apoptosis. 
The ER stress, which is caused by an increased secretory demand to compensate 
for insulin resistance is further aggravated by a FA induced ER dysfunction in β-cells [32, 
33]. IRE-1α triggers several signaling routes, which provoke a combination of pro-
survival and pro-apoptotic responses. The RNase domain of IRE-1α cuts a short sequence 
from the XBP-1 mRNA, thus yielding a so called spliced mRNA (sXBP-1 mRNA), and 
giving rise to the XBP-1 transcription factor, which in turn induces various ER 
chaperones and proteins of ER-associated degradation (ERAD) [34]. IRE-1α also causes 
activation of JNK, a central stress kinase that promotes apoptotic cell death [35]. The 
kinase domain of PERK phosphorylates the α subunit of eIF2 protein, which leads to the 
inhibition of protein translation by blocking the initiation step [36, 37]. As a result of the 




and there is more time for the cell to correct the misfolded proteins. Another result of the 
eIF2α phosphorylation is the increase in the expression of activating transcription factor 
4 (ATF-4) [38]. ATF-4 promotes the transcription of genes which are responsible for 
restoring the homeostasis, and on the other hand, it increases the transcription of the 
proapoptotic C/EBP homologous protein (CHOP) [39]. In the presence of misfolded 
proteins, ATF-6 is translocated to the Golgi-apparatus and is cleaved by Site-1 and Site-
2 proteases (S1P and S2P). The N-terminal of the cleaved ATF-6 with the help of XBP-
1 protein takes part in the restoration of the size and permeability of the ER changed by 
the stress [40]. During ER stress the induction of both chaperons, the BiP and PDI, are 
linked to ATF-6. The cleaved ATF-6 enters the nucleus, where it induces the transcription 
of UPR target genes, such as BiP and PDI, increasing the amount of these chaperons [41, 
42]. BiP regulates the signalization steps during the UPR, and it can also inhibit the 
activation of the caspase cascade, functioning as an antiapoptotic protein [43]. In the 
process of protein folding, PDI helps in the formation of disulfide bonds, which are 
needed for the correct protein folding. 
In case the mechanisms of the UPR cannot restore the homeostasis, the constant 
activation of the signalization pathways leads to chronic ER stress. In such cases, the UPR 
is transformed to an alternative signalization complex, which is called terminal UPR and 
it actively promotes apoptosis. All three of the pathways activated during the UPR contain 
a proapoptotic elements, such as B-cell lymphoma 2 (Bcl-2), thioredoxin interacting 
protein (TXNIP), apoptosis signal-regulating kinase 1 (ASK1), and JNK, which promotes 
the development of programed cell death, when the progress of the ER stress is 
irreversible [44-46]. 
1.4. Apoptosis 
As we have seen, apoptosis can be induced by a chronic and/or severe ER stress. 
It has been established that a persistently high amount of FAs leads to the development 
of lipotoxicity, including the induction of ER stress [4, 34]. The apoptosis developed 
because of sustained lipotoxicity is a certain type of programmed cell death, and it is 
called lipoapoptosis. The apoptotic cells interrupt their connection to their environment, 
do not receive signals and inhibit their gene expression. Their DNA, nucleus and 




apoptotic bodies. The cells undergoing apoptosis use so called “eat me” signals to 
indicate, for other cells in their surroundings, that they are readily available for 
phagocytosis. In this process, the accumulation of phosphatidyl serine on the surface of 
the plasma membrane plays a central role. This also creates an opportunity to detect 
apoptosis in experimental conditions. The commercially available, fluorescent Annexin 
binds with great affinity to the phosphatidyl serine rich region of the membrane [47]. 
These fluorescent regions can be detected by different methods, offering a variety of 
possibilities for the detection of apoptotic cells even in early stage of the process. 
Apoptosis is the terminal program of the cell, which is executed mostly by caspases [48]. 
These proteases cleave the so called death substrates in the right recognition site and the 
cleavage of hundreds of these death substrates is responsible for the caspase dependent 
pathway of apoptosis. The most important effector caspase is Caspase-3, which is 
activated by limited proteolysis, and hence detection of its cleaved fragments is 
commonly used to estimate the intensity of apoptosis [49]. 
Among the different pathways of apoptosis, the mitochondrial pathway, which is 
based on the protein efflux from the intermembrane region of the organelle, exceeds the 
others. One portion of these proteins entering the cytosol induces the caspase dependent 
pathway, while the other portion reaches the nucleus, where it fragments and deconstructs 
the DNA and the chromatin structure in a caspase independent manner. The increase in 
permeability of the mitochondrial outer membrane is caused by the channels created by 
members of the Bcl-2 multidomain proapoptotic protein family [50]. These, such as Bcl-
2 homologous antagonist/killer (BAK) and Bcl-2 associated X (BAX), are necessary for 
the execution of a classic and typical apoptosis. In the last decade, we managed to get to 
know the details of the mechanism of apoptosis generated by ER stress and the UPR. 
Among these of outstanding importance is JNK activation by IRE-1α, since the JNK by 
phosphorylating the Bcl-2 proteins increases the permeability of the mitochondria [51]. 
Induction of the expression of proapoptotic CHOP protein is managed by more than one 
element of the UPR. These mechanisms contribute greatly to the development of the ER 
stress mediated apoptosis, because CHOP not only induces the expression of some of the 
proapoptotic genes (death receptor 5 and Bcl-2 like protein 11), but also inhibits the 




stress, also contributes to the mitochondrial dysfunction, which forces the cells in the 
direction of apoptosis [11]. 
1.5. Toxicity of saturated and unsaturated fatty acids 
The induction of ER stress contributes to cell death and reduces β-cell mass 
through apoptosis [53, 54]. This phenomenon is further exasperated by the accumulation 
of ceramide intermediates [18, 19]. 
A greater toxicity of the saturated palmitate compared to cis-unsaturated oleate 
has been demonstrated in several studies [55, 56]. In contrast, very little is known about 
the toxicity of dietary trans-fatty acids (TFAs) and even those findings contradict each 
other. Although double bonds of trans configuration in FAs are not formed by human 
enzymes, most people ingest considerable amounts of TFAs. Formation of a trans-11 
double bond by isomerization is the first step of microbial unsaturated FA 
biohydrogenation in the digestive system of ruminant animals [57], and this makes tallow, 
beef, milk, and other dairy products natural sources of TFAs, mainly vaccenate (18:1 
trans-Δ11). TFAs are also produced artificially via industrial hydrogenation of vegetable 
oils; however, the predominant TFA in margarine is elaidate (18:1 trans-Δ9), a positional 
isomer of vaccenate and a geometric isomer of oleate [58]. TFAs have been shown to 
exert various deleterious health effects in vivo, and chronic TFA intake has been found to 
be associated with the risk of type 2 diabetes [59]. Some studies have shown a difference 
between the harmfulness of the natural vaccenate and the industrial elaidate [60], and 
some studies have suggested that limited amounts of TFAs improve life expectances [61, 
62]. Although the results of in vivo studies on the health impacts of trans fat consumption 
are often contradictive, and very little data is available on the metabolic fate and cellular 
toxicity of TFAs, these food components are widely considered as harmful, and current 
legislations aim to eliminate them from food products in several countries [63]. 
Not only has it been repeatedly demonstrated that saturated FAs are more harmful 
than the unsaturated ones, the ability of oleate to reduce the toxicity of palmitate has also 
been reported, and it has also become a widely investigated phenomenon. Administration 
of oleate and palmitate at the same time was shown to be less toxic than palmitate alone 
in various cell types [64, 65]. It also has been observed that activation of the UPR 




of oleate [66]. These observations raised a very interesting question, whether or not the 





High FA levels cause ER stress and apoptosis in β-cells, largely due to ceramide 
and diglyceride accumulation. The deleterious effect of the saturated palmitate (16:0) is 
much more pronounced than that of cis-unsaturated oleate (18:1 cis-Δ9). It is also 
described in the literature that the simultaneous addition of oleate can mitigate the effects 
of palmitate. Despite their importance, very little information is available on the effects 
of dietary TFAs, such as elaidate (18:1 trans-Δ9) and vaccenate (18:1 trans-Δ11) and their 
health effects are even more obscure due to the contradictory data. Although it is true that 
humans are not able to synthetize FAs with double bonds in trans configuration, we 
consume plenty of TFAs in the 21st century. Based on these facts, the aim of our 
investigation was: 
- to compare the toxicity of the two major dietary TFAs (i.e., elaidate and 
vaccenate) with that of the best studied endogenous saturated and cis-unsaturated FAs 
(i.e., palmitate and oleate) in RINm5F cells, 
- to determine the change in FA profile and in the ceramide and diglyceride levels 
after palmitate, oleate, elaidate and vaccenate treatment, 
- to test the potential mitigating effect of elaidate and vaccenate on palmitate-
induced toxicity,  
- to investigate how oleate, elaidate and vaccenate influence palmitate-induced 
alterations in the FA profile and the intracellular accumulation of ceramides and 
diglycerides. 
We carried out our experiments on RINm5F rat insulinoma cell line since it is 
widely used to investigate β-cell apoptosis, including lipoapoptosis, and the experimental 
parameters were already successfully adjusted in our laboratory during the investigation 
of the protective effect of metformin against palmitate induced ER stress and cell death 
[34]. We estimated the cell viability and the intensity of apoptosis. The accountable ER 
stress and phosphorylation of stress-activated protein kinase (SAPK)/c-Jun N-terminal 
kinase (JNK) were also observed. In addition, the amounts of the most relevant FAs were 






3.1. Effects of palmitate and various unsaturated fatty acids on RINm5F cell 
viability 
The toxicity of saturated palmitate has been investigated in RINm5F cells earlier 
in our laboratory [34, 67]. In the present study, RINm5F cell survival was estimated after 
24-hour long treatments with different FAs and their combinations at 250 or 500 µM 
concentration separately by using MTT assay. In accordance with our and others’ 
previous results, palmitate was found to decrease the cell viability in a dose dependent 
manner.  The number of viable cells dropped to about 40% and below 20% of the control 
value after 250 and 500 µM palmitate treatment, respectively (Fig. 2). Cell viability in 
samples treated with oleate was much higher, as expected based on previous observations. 
The comparison between the three observed unsaturated FAs did not show any difference. 
Neither the cis- nor trans-unsaturated FAs reduced the viability significantly at 250 µM 
concentration, nor did the damage caused by them reach the levels caused by palmitate at 
500 µM (Fig. 2). In combination treatment with oleate, the damage caused by palmitate 
was lessened significantly in accordance with several earlier observations. Importantly, 
in case of the trans-unsaturated elaidate and vaccenate co-treatment, significant viability 
improvements could also be observed too. At 250 µM FA concentration, the cis-
unsaturated oleate improved the viability of palmitate-treated cells by 40%, while the 
trans-unsaturated FAs lessened the toxicity of palmitate by at least 20%. At higher, 500 
μM concentration the oleate co-treatment resulted in a 30% viability improvement, and 
the amount of viable cells also increased by 20% upon TFA co-treatment. It is also 
remarkable that no obvious difference was observed between the protective effect of the 




Figure 2. Cell Viability. RINm5F insulinoma cells were treated with BSA (control cells) 
or BSA-conjugated palmitate, elaidate, oleate or vaccenate alone, or with palmitate and 
one of the unsaturated FAs at two concentrations (250 or 500 µM) at 70-80% confluence 
and incubated for 24-hours. Cell viability was measured by Colorimetric (MTT) Kit for 
Cell Survival and Proliferation (Millipore) and expressed as the percentage of Control. 
Data are shown as mean values ± S.D. of six experiments; statistically significant 
differences: ! P <0.05, v.s. BSA-treated control; *P <0.05, v.s. palmitate treated cells. 
3.2. Fatty acid-induced apoptosis 
Apoptosis is one of the major factors in β-cell lipotoxicity. To reveal the 
contribution of apoptotic cell death in the change of cell viability, apoptotic index was 
determined. After an 8-hour long FA treatment, the number of apoptotic cells among 100 
total cells was counted with fluorescence microscopy. Palmitate treatment caused a 




caused a small and statistically not significant elevation in the apoptotic index when 
compared to the control level. A distinct change can be observed upon unsaturated FA 
co-treatments compared to palmitate-treated cells, as the simultaneously added 
unsaturated FAs lessened the amount of apoptotic cells significantly. The amount of the 
apoptotic cells in these co-treated samples does not show statistically relevant difference 
from the control (Fig. 3). 
Figure 3. Apoptosis index. The cells were treated with BSA (control cells) or BSA-
conjugated palmitate, elaidate, oleate or vaccenate alone or in combination with palmitate 
and one of the unsaturated FAs at 500 µM concentration for 8-hours at 70-80% 
confluence, in 96-well plates. Apoptosis index was calculated as the relative number of 
apoptotic cells and expressed as percentage of the total cell number. Apoptotic cells were 
detected and counted by annexin and propidium iodide staining and fluorescence 
microscopy. Typical microscopic images obtained in three independent experiments and 
data are shown in the diagram as mean values ± S.D. of three experiments; ! P <0.05, v.s. 
BSA-treated control; *P <0.05, v.s. palmitate-treated cells. 
By investigating the caspase-3 activation levels after the different FA treatments, 
further proofs can be found about the effects of different FAs on apoptosis. As expected 
based on the results shown above, the amount of cleaved caspase-3 was found to increase 
at least 10-fold in palmitate-treated cells compared to control levels (Fig. 4). The single 
treatment with one of the unsaturated FAs revealed a slightly higher level of caspase-3 
than the control cells. The difference was most noticeable, but still not significant, in case 
of vaccenate (Fig. 4). The cells co-treated with palmitate and one of the unsaturated FAs 
contained lower amount of the cleaved caspase-3 enzymes compared to palmitate alone 
treatment. Oleate caused a remarkable, 55% decrease in the cleaved caspase-3 levels 




decrease can be observed, the co-treatment with vaccenate caused a 25% decrease in the 
enzyme levels, which was deemed non-significant by the statistical analysis (Fig. 4). 
Figure 4. Cleaved Caspase-3 levels. The cells were treated with BSA (control cells) or 
BSA-conjugated palmitate, elaidate, oleate or vaccenate alone or in combination with 
palmitate and one of the unsaturated FAs at 500 µM concentration for 8-hours at 70-80% 
confluence, in 6-well plates. Cleaved Caspase-3 was detected by western blot in cell 
lysates. The results were quantified by densitometry, normalized to GAPDH as a 
constitutive reference protein and are shown as relative band densities in the percentage 
of palmitate values. The western blot image shows typical results of three independent 
experiments with two parallels. Data are shown in the diagram as mean values ± S.D. of 
three experiments; ! P <0.05, v.s. BSA-treated control; *P <0.05, v.s. palmitate-treated 
cells. 
3.3. Induction of ER stress 
Lipotoxicity is a complex process, which involves numerous signaling pathways, 
some of which belong to the cellular mechanism of ER stress. The earliest momentum of 
the UPR involves the excision of 26 nucleotides from the so-called unspliced version of 
XBP-1 (uXBP-1) mRNA, a process catalyzed by the IRE-1 ER stress receptor. The 
resulting spliced (sXBP-1) mRNA codes for a transcription factor and it is also a specific 
marker of the ER stress and the UPR. For better visualization, the IRE-1 mediated splicing 
was detected by endonuclease cleavage. After palmitate treatment, an enhanced splicing 
was observed, resulting in a more than 5-fold increase in the sXBP-1/uXBP-1 ratio, in 




of the ratio compared to control (Fig. 5A). The addition of oleate next to palmitate caused 
the ratio to diminish by almost 50% compared to palmitate alone. The TFA co-treatment 
also resulted in a moderation of sXBP-1/uXBP-1 ratio, where elaidate proved to be the 
less effective, resulting in a significant 30% decrease, while vaccenate caused an almost 
40% lessening in the ratio compared to palmitate (Fig. 5A). 
Figure 5. Endoplasmic reticulum stress markers. The cells were treated with BSA 
(control cells) or BSA-conjugated palmitate, elaidate, oleate or vaccenate alone or in 
combination with palmitate and one of the unsaturated FAs at 500 µM concentration for 
8-hours at 70-80% confluence, in 6-well plates. (A) After treatment total RNA was 
prepared and a 447 and a 421 bp long sequence was amplified by RT-PCR from sXBP-1 
and uXBP-1 mRNA, respectively. For better visualization the two versions were further 
digested by PstI restriction endonuclease, which leaves the spliced cDNA uncut (421), 
while cleaves the unspliced cDNA to two fragments (153 and 294 bp). The digested 
samples cDNAs were separated by 2% agarose gel electrophoreses, the band densities 




typical gel image obtained in one of three independent experiments is presented. (B) From 
the samples phosphorylated eIF2α (P-eIF2α), 78 kDa glucose-regulated protein 
(GRP78/BiP), protein disulfide isomerase (PDI), phosphorylated SAPK/JNK isoforms 
(P-JNK 1/2) protein levels were detected by western blot. The western blot images show 
typical results of three independent experiments. The results were quantified by 
densitometry, normalized to overall GAPDH levels and are presented as relative band 
densities in the percentage of palmitate-treated samples. Data are shown as mean values 
± S.D. of three experiments; ! P <0.05, v.s. BSA-treated control; *P <0.05, v.s. palmitate-
treated cells. 
The other major signalization pathway of the ER stress is closely associated to 
PERK. Thus, as a PERK-mediated ER stress marker, the eIF2α phosphorylation was 
assessed, by comparing the levels of phosphorylated and overall eIF2- α levels. Palmitate 
caused a significant increase in the P-eIF2α levels compared to control cells, while the 
single treatments with unsaturated FAs were deemed insignificant (Fig. 5B). After the co-
treatment with unsaturated FAs, a remarkable decrease could be observed in case of the 
cis-unsaturated oleate as it diminished the phosphorylated eIF2α amount by almost 70%. 
The trans-unsaturated vaccenate was almost as potent as oleate, while the trans-elaidate 
treatment resulted in a 25% symbolic, but non-significant decrease in the P-eIF2α levels 
(Fig. 5B). As the stress conditions remain for a longer period of time, the expression of 
ER chaperons grows as an important adaptive element of the UPR. The chaperon 
development comes with a delay as generally the transcriptional regulations do. As long-
term ER stress markers, two main ER chaperons, the BiP and PDI were investigated by 
western blotting. In both cases, the 8-hour long FA treatment did not result in any 
elevation in the amount of the proteins mentioned above (Fig. 5B). 
The JNK phosphorylation is connected to lipotoxicity because, as a major stress 
kinase among others, it is sensitive to oxidative and ER stress and it is also activated by 
inflammation and ceramide accumulation. The enzyme is activated by phosphorylation 
and helps in the development of insulin resistance and apoptosis. The isoforms of the 
activated JNK were detected by immunoblotting and as expected, the palmitate raised the 
phosphorylation of the JNK five-fold compared to control samples, while the three 
unsaturated FAs caused a much smaller increase in JNK phosphorylation (Fig. 5B). The 
co-treatment with the cis-unsaturated oleate remarkably decreased the amount of the 
activated JNK and the level was slightly, but not significantly higher than the control. 
Interestingly, however, the TFAs did not change the JNK phosphorylation significantly; 




proven to be non-significant by the statistical analysis, while vaccenate did not cause any 
notable changes (Fig. 5B). 
3.4. Changes in the fatty acid profile of the cells 
During a 24-hour long treatment, the incorporation of the FAs in question were 
observed in different times. After the extracellular FAs were removed, the FA profile of 
adherent cells was constructed with saponification and esterification of complex lipids 
followed by a gas chromatography coupled to flame ionization detector (GC-FID) 
measurement. The investigation proved that all of the FAs were incorporated into the cells 
efficiently, though with different time courses. Palmitate and oleate reached their 
maximum levels after 8 and 16-hours of incubation (Figs. 6 and 7).  
In case of the single treatments, the trans-unsaturated elaidate and vaccenate 
topped at 24-hour (Fig. 6). The amount of palmitate and elaidate increased by about 150 
μg/mg protein, that of oleate and vaccenate increased by about 100 μg/mg protein above 
the control levels. Since the cells contained substantial amounts (nearly 50 μg/mg protein) 
of palmitate and oleate originally, the maximum level of palmitate was the highest (above 
200 μg/mg protein) and that of vaccenate was the lowest (below 100 μg/mg protein) 
among the 4 FAs added (Fig. 6). 
Although the same concentration of palmitate was applied in single and co-
treatments, intracellular amount of palmitate in co-treatments did not reach at any given 
time the values observed after palmitate alone treatment, and remained at around 65 
μg/mg protein in all combinations (Fig. 7).  
As a result of desaturation and elongation, an elevation can be observed in stearate 
and cis-palmitoleate (16:1 cis-Δ9) levels after palmitate treatment. Interestingly, the 
addition of both TFAs caused an obvious accumulation of its degradation intermediate 
(16:1 trans-Δ7 or 16:1 trans-Δ9 in case of elaidate or vaccenate, respectively), which was 
in a striking contrast to oleate, as the concentration of 16:1 cis-Δ7 FA did not increase in 
oleate-treated cells (Fig. 6). The increase of degradation intermediates can be detected in 





Figure 6. Fatty acid profile of RINm5F cells after single treatments. The cells were 
treated with palmitate, elaidate, oleate or vaccenate (250 µM) at 70-80% confluence, in 
6-well plates. Cell samples were withdrawn at 4, 8, 16 and 24 h times of incubation, and 
the amount of 10 different saturated and mono-unsaturated FAs was measured by GC-
FID after saponification and methylation. Data were analyzed of three independent 





Figure 7. Fatty acid profile of RINm5F cells after co-treatments. The cells were 
treated with palmitate or in combination with palmitate and elaidate, oleate or vaccenate 
(250 µM) at 70-80% confluence, in 6-well plates. Cell samples were withdrawn at 4, 8, 
16 and 24-hour times of incubation, and the amount of 10 different saturated and mono-




were analyzed of three independent experiments with two parallels and normalized to the 
total protein content of the samples. 
3.5. Diglyceride levels 
The excess acyl-CoA can cause an increased ER stress and apoptotic tendency, 
which is detrimental, especially for β-cells. Triglyceride synthesis is an efficient way for 
the cells to eliminate the acyl-CoA surplus, but an uneven saturated and unsaturated FA 
supply can result in a DG build-up. The LC-MS/MS measurement revealed an increase 
in the amount of the most important DG types containing 16 and 18 long carbon chains 
from saturated and mono-unsaturated FAs. In case of the palmitate treatment, the most 
outstanding elevation can be observed after 8-hour long treatment, where the levels of 
1,2-dipalmitoyl-glycerol (16:0/16:0), 1-palmitoyl-2-stearoyl-glycerol (16:0/18:0), 
1,2-distearoyl-glycerol (18:0/18:0), 1-palmitoyl-2-palmitoleoyl-glycerol (16:0/16:1) 
were increased by at least 45-fold, 18-fold, 8-fold and 5-fold, respectively. A gentle 
elevation can be observed in the concentration of 1-palmitoyl-2-oleoyl-glycerol 
(16:0/18:1), while the levels of 1-stearoyl-2-oleoyl-glycerol (18:0/18:1) and 1,2-dioleoyl-
glycerol (18:1/18:1) remained practically unaffected. Altogether the palmitate treatment 
caused a 17-fold increase in the overall DG levels compared the control cells (Figs. 8 and 
9). 
Figure 8. Diglyceride accumulation after single fatty acid treatments. The cells were 
treated with palmitate, elaidate, oleate or vaccenate (250 µM) at 70-80% confluence, in 6 




the amount of 7 major diglycerides was measured by LC-MS/MS. Data were normalized 
to the total protein content of the samples, and are shown as mean values of three 
independent experiments with two parallels. S.D. was below 10% of the mean values in 
all cases.  
Figure 9. Effect of unsaturated fatty acid co-treatment on diglyceride accumulation. 
The cells were treated with palmitate or in combination with palmitate and elaidate, oleate 
or vaccenate (250 µM) at 70-80% confluence, in 6-well plates. Cell samples were 
withdrawn at 4, 8, 16 and 24 h times of incubation, and the amount of 7 major diglycerides 
was measured by LC-MS/MS. Data were normalized to the total protein content of the 
samples, and are shown as mean values of three independent experiments with two 
parallels. S.D. was below 10% of the mean values in all cases. 
The effects of oleate treatment differed greatly from those of palmitate. The 
increase in overall DG level was the largest at 4 h of oleate treatment, when its amount 
tripled (9.9 μg/mg protein v.s. 3.2 μg/mg protein in oleate-treated and control, 
respectively). This change was caused by an 18-fold increase in 1,2-dioleoyl-glycerol 
(18:1/18:1) and a 2-fold increase in 1-palmitoyl-2-oleoyl-glycerol (16:0/18:1) and 1-
stearoyl-2-oleoyl-glycerol (18:0/18:1) content (Fig. 8). It is also notable that the amounts 
of those four DGs, i.e., 1,2-dipalmitoyl-glycerol (16:0/16:0), 1-palmitoyl-2-stearoyl-
glycerol (16:0/18:0), 1,2-distearoyl-glycerol (18:0/18:0) and 1-palmitoyl-2-palmitoleoyl-
glycerol (16:0/16:1), which are the most markedly elevated in palmitate-treated cells, 
were found to be 5-10-fold decreased in oleate-treated cells at all times. More or less the 
same changes can be observed in the cells after TFA treatment. The overall DG amount 




induced by oleate: they were increased 5-fold (14.8 μg/mg protein v.s. 3.2 μg/mg protein) 
and 6-fold (18.0 μg/mg protein v.s. 3.2 μg/mg protein) in case of elaidate and vaccenate, 
respectively at 4 h of incubation, and it was mostly due to a 27-28-fold increase in the 
levels of DGs containing only elaidate or vaccenate (18:1/18:1). The accumulation of 1-
palmitoyl-2-elaidyl-glycerol and 1-palmitoyl-2-vaccenyl-glycerol was also more 
noticeable than that of 1-palmitoyl-2-oleoyl-glycerol (16:0/18:1) (Fig. 8). 
An increase in the overall DG content in the palmitate plus oleate co-treatment 
was also observed, but the elevation was only two-fold, which was considerably lower 
than that seen after palmitate alone. Another noteworthy difference from single treatments 
is in the time-course and the pattern of the effect. The overall DG levels were kept stable 
during the experiment, and the contribution of DG species containing 18 carbon long 
unsaturated chains were similar to those containing only palmitoyl, palmitoleoyl and/or 
stearoyl groups (Fig. 9). Briefly, almost all of the DG levels showed a less pronounced 
increase during the co-treatment, and the biggest difference was observed at the levels of 
the two most abundant DGs, where a 10-times lower level compared to palmitate treated 
cells could be seen after 8-hour of combined FA incubation (68.3 μg/mg protein v.s. 6.3 
μg/mg protein and 11.5 μg/mg protein v.s. 1,3 μg/mg protein). Interestingly, the 
concentration of the 1-stearoyl-2-oleoyl-glycerol (18:0/18:1) and 1,2-dioleoyl-glycerol 
(18:1/18:1) increased through the whole course of palmitate-oleate co-treatment, reaching 
their maximum at 1.5 μg/mg protein and 2.4 μg/mg protein, respectively (Fig. 9). Co-
treatments with one of the two TFAs induced yet another course of DG accumulation The 
overall DG kept increasing and reached their maximum after 16-hour long incubation, 
where elaidate produced a 44.1 μg/mg protein and vaccenate a 34 μg/mg protein overall 
level, which is twice the amount compared to oleate. This difference is mostly caused by 
the 1,2-dipalmitoyl-glycerol (16:0/16:0), the 1-palmitoyl-2-oleoyl-glycerol (16:0/18:1) 
and the 1,2-dioleoyl-glycerol (18:1/18:1), as their levels got increased by more than 3 
times in elaidate and approximately 2 times in vaccenate co-treatment, except the 1,2-
dipalmitoyl-glycerol, where the levels doubled in both cases. Comparing the two TFAs 
to each other, it is apparent that the elaidate co-treatment produced more DGs in almost 
all cases and the amount of stearoyl-2-oleoyl-glycerol (18:0/18:1) is nearly twice of the 




3.6. Ceramide levels 
Ceramides as toxic lipid intermediates, which are composed of one fatty acyl 
chain and a sphingosine, are closely related to lipotoxicity. Therefore, we determined the 
concentration of those ceramides, which contain one of the administered FAs by LC-
MS/MS measurement. The most abundant ceramides in BSA-treated control cells were 
palmitoyl- and stearoyl-sphingosines (16:0 and 18:0) with about 1 μg/mg protein and 250 
ng/mg protein levels, respectively, while oleoyl-sphingosine (18:1) was barely detectable 
(about 10 ng/mg protein) (Figs. 10 and 11). Palmitate treatment caused a 6-fold increase 
in the overall ceramide levels, compared to control cells, and the increase reached its 
maximum after an 8-hour long incubation. This change was due to palmitoyl- and 
stearoyl-sphingosines (16:0 and 18:0) as their levels increased by about 3.9 μg/mg protein 
and 2.1 μg/mg protein levels, respectively, while change in the oleoyl-sphingosine (18:1) 
was much smaller (about 14,8 ng/mg protein). 
 
Figure 10. Changes in ceramide levels after single treatments. The cells were treated 
with palmitate, elaidate, oleate or vaccenate (250 µM) at 70-80% confluence, in 6-well 
plates. The amount of three different ceramide species was measured by LC-MS/MS in 
the cell samples prepared after 4, 8, 16 or 24 hour treatments. The detected ceramides 
contained either a palmitate (16:0) or a stearate (18:0) or a mono-unsaturated FA of 18 
carbons (18:1). Data were normalized to the total protein content of the samples, and are 
shown as mean values of three independent experiments with two parallels. S.D. was 





Figure 11. Effect of unsaturated fatty acid co-treatment on ceramide accumulation. 
The cells were treated with palmitate or in combination with palmitate and elaidate, oleate 
or vaccenate (250 µM) at 70-80% confluence, in 6-well plates. The amount of three 
different ceramide species was measured by LC-MS/MS in the cell samples prepared after 
4, 8, 16 or 24 hour treatments. The detected ceramides contained either a palmitate (16:0) 
or a stearate (18:0) or a mono-unsaturated FA of 18 carbons (18:1). Data were normalized 
to the total protein content of the samples, and are shown as mean values of three 
independent experiments with two parallels. S.D. was below 10% of the mean values in 
all cases. 
In line with its smaller cytotoxicity, oleate increased the overall ceramide level 
much less. Although the accumulation of oleoyl-sphingosine (18:1) can be observed in 
the cells (66.0 ng/mg protein v.s. 12.2 ng/mg protein at 24 h in oleate-treated v.s. control 
cells, respectively), the concentration of the most abundant ceramide species did not 
change (palmitoyl-sphingosine, 16:0) or decreased to less than half of control level 
(stearoyl-sphingosine, 18:0) (Fig. 10). The formation of elaidyl- and vaccenyl-
sphingosines in TFA treated cells was an order of magnitude above that of oleoyl-
sphingosine upon oleate treatment, which is a conspicuous difference between cis-oleate 
and the two TFAs. An increase of 658.4 ng/mg protein of elaidyl-sphingosine, 431.4 
ng/mg protein of vaccenyl-sphingosine and 53.8 ng/mg protein of oleoyl-sphingosine was 




differences were also reflected by the alterations of the overall ceramide level, since the 
three unsaturated FAs had otherwise similar effects on the other investigated ceramide 
species. The amount of these ceramides nearly doubled in the TFA-treated cells and 
increased by only by 30% in oleate-treated cells in the longest incubations (Fig. 10). 
The simultaneous addition of oleate to palmitate-treated cells caused a much 
smaller accumulation in the overall ceramide levels. Oleate mitigated the formation of 
palmitoyl- and stearoyl-sphingosines (16:0 and 18:0), however, despite the excess of 
oleate only a slight elevation (26.5 ng/mg protein) can be observed in case of the oleoyl-
sphingosine (18:1) (Fig. 11). The TFAs, had a somehow similar effect like oleate, as they 
were almost as effective as oleate in the reduction of palmitoyl- and stearoyl-sphingosine 
(16:0 and 18:0) levels, but a much more pronounced elevation in elaidyl- and vaccenyl-
sphingosines (18:1) was observed. Their amount reached to as high as 487 ng/mg protein 
in the case of elaidate, and 448 ng/mg protein concentration in the case of vaccenate co-





A well-balanced diet is a major contributing factor to health or disease. Some of 
the most relevant obesity-related pathologies are type 2 diabetes, the metabolic syndrome 
and cardiovascular diseases. Several components in the diet can modulate the 
development of these pathological conditions, such as dietary fats, specifically, saturated 
and mono-unsaturated FAs. Excessive palmitic acid, the most abundant FA in food, has 
been shown to be effective in causing ER stress [68] and, consequently, the accumulation 
of TGs rich in palmitic acid in the cells [69]. Evidence suggests a crucial role of palmitic 
acid in β-cell failure via serine phosphorylation of insulin receptor substrate (IRS) 
proteins [70]. This leads to the development of insulin resistance, which forces the β-cells 
to increase the degree of insulin secretion, which in turn leads to an adaptive ER stress in 
these cells. The increased demand and the presented lipotoxicity, which also affects the 
β-cells, coupled with the ER stress is a condition which could eventually lead to β-cell 
apoptosis [23]. While the different species of dietary FAs contribute differently to 
lipotoxicity, a great amount of experiments demonstrated that saturated FAs, particularly 
palmitic acid, are the most able to trigger lipotoxicity [33, 71, 72]. In comparison, 
unsaturated FAs are less toxic. Oleic acid is a mono-unsaturated FA, which is naturally 
formed in the human body by stearoyl-CoA desaturase [73, 74]. Just like that of palmitate, 
the toxicity of oleate has been thoroughly investigated and it has been proved that it is 
less pronounced compared to the former [18]. One of the configurational isomers of oleate 
is elaidate, which can be produced by industrial processing of plant oils, as some of the 
cis double bonds get rearranged to trans position during industrial hydrogenation. The 
global consumption of these products, such as margarine, drew attention to these TFAs. 
They have been branded as the worst type of FAs, which are at least partly responsible 
for the health risks associated with the consumption of fast-foods [59, 75]. Considering 
these hypotheses, some countries restricted or prohibited the TFA content of nutrition, 
despite that the observations are based on contradictory in vivo experiments, and in the 
lack of sufficient in vitro investigations [76, 77]. It is also interesting that the TFA 
produced by bacterial isomerization, namely vaccenate, which is consumed with dairy 
products such as butter and ruminant meat, is deemed natural and is excepted from the 




In our study, we compared the toxicity of the above mentioned two TFAs to two 
most typical saturated and cis-unsaturated FAs, palmitate and oleate, using a previously 
established cellular model of lipotoxicity in an insulinoma cell line [34]. Viability tests 
were undertaken by administering BSA-conjugated FAs to the cells in toxic 
concentrations (250 and 500 μM) for 24 h. In our experiment, the effects of palmitate 
were in line with the literature, as it decreased the viability of the cells by at least 60% 
and 85%, at the two concentrations respectively. The induction of apoptosis and ER stress 
was investigated at 500 μM concentration after 8 h of FA incubation. The toxic effects of 
palmitate were obvious and complied with the data previously observed. The unsaturated 
FAs were administrated in the same conditions and while the effects of oleate were similar 
to those already described in publications, interestingly the TFA treatments brought 
similar results to that of oleate regarding viability, apoptosis and ER stress, in single 
treatments. Even more noticeably, no conspicuous difference was observed between 
elaidate and vaccenate, despite the observations reported in in vivo studies. 
Cellular FA uptake is determined primarily by the availability of FFA, while fatty 
acyl-CoA utilization is limited by the capacities of the relevant metabolic pathways, 
therefore FFA abundance leads to high levels of fatty acyl-CoA in the cells. Ceramides 
and DGs are biosynthetic intermediates that are implicated in lipotoxicity, especially in 
β-cells. Increased uptake of FFAs is a major mechanisms underlying triglyceride 
accumulation [80]. TG synthesis provides a major route to drain the intracellular acyl-
CoA pool. However, the efficient completion of this pathway requires the insertion of an 
unsaturated FA at carbon-2 of glycerol, and hence TG synthesis is largely hindered by an 
overwhelming supply of saturated FAs [81]. This provides a plausible explanation for the 
higher toxicity of unbalanced saturated FAs. Ceramides represent a class of lipids which 
combines cell toxicity with ER stress and apoptosis. They are implicated in insulin 
resistance, inflammation, oxidative stress and cell death and may be generated de novo 
from serine and palmitoyl-CoA, via serine palmitoyltransferase [82]. An alternative 
pathway is based on the action of neutral sphingomyelinase, which catalyzes the release 
of ceramides from membrane sphingomyelin [83, 84].  
Our investigation on palmitate-treated cells revealed an accumulation of DGs 
containing two saturated fatty acyl chains, which are rarely present in control cells. While 




DGs remained far behind the levels observed after palmitate treatment, the TFAs induced 
a much greater accumulation in the DG content compared to oleate, and the rise is mostly 
limited to DGs containing one or two chains of the given unsaturated FA. It is possible 
that the accumulation of these DGs is caused by an interference of TG synthesis, as the 
TFA chains might disturb the third acylation during the process, but the exact process is 
yet to be determined. Beside these changes, we observed a several-fold increase in the 
ceramide content after palmitate treatment. The unsaturated FAs, either cis or trans, 
caused a much smaller change in the overall ceramide levels, although the presence of 
ceramides containing TFA chains was noteworthy, and interestingly was much more 
pronounced than the production of oleoyl-sphingosine. To explain the difference, further 
studies are needed, but it can be due to a different affinity to sphingosine acyltransferase 
or a problem in the utilization of ceramides containing TFAs. Either way, a prolonged 
TFA consumption can lead to higher intracellular ceramide concentrations, which 
ultimately can cause a more prominent toxicity. Both in the toxicity and the incorporation 
into complex lipids, the TFAs in our investigations were found to be more similar to 
oleate than to palmitate. This seems to confirm the connection between the accumulation 
of ceramides and DGs and the intensity of cell damage. These findings do not support 
either the deleterious health effects of TFAs in general, or the often suggested difference 
between the industrial elaidate and the natural vaccenate. It is true, however, that diabetes 
is not the only pathology, which has been suspected to be associated to TFA consumption, 
and β-cells are not the only potential targets of TFA toxicity. Our study also revealed 
differences between the metabolism of the investigated unsaturated FAs, which were not 
reflected in the short-term toxicity but might be important in the long run for the health 
effects of chronic consumption of dietary FAs.  
In a recent study, the incorporation of TFAs in cellular lipids has been reported. 
The investigation revealed that in endothelial (HUVEC) and hepatoma (HepG2) cells, the 
TFAs suppress TNF-α-induced inflammatory gene expression [85]. In our study, the FA 
profile revealed that the beneficial trans-palmitoleate (16:1 trans-Δ9) [61, 86], is not only 
ingested with food, but it is also produced endogenously as a partially degraded 
intermediate of vaccenate (18:1 trans-Δ11) [87]. It is noteworthy that vaccenate, the major 
TFA in ruminants, has been shown to reach high proportions also in industrially partially 




(16:1 trans-Δ9) and its positional isomer (16:1 trans-Δ7), in the TFA-treated cells. They 
are the shortened derivatives of vaccenate and elaidate likely produced as intermediates 
of β-oxidation. However, in cells treated with oleate the analogous cis intermediate of β-
oxidation (16:1 cis-Δ7) was not elevated in spite of higher intracellular oleate contents. 
A possible reason for this phenomenon might be due to a potentially different affinity of 
mitochondrial long-chain acyl-CoA dehydrogenase (LCAD) to cis or trans unsaturated 
FAs. The difference in the affinity of 5-trans-tetradecenoyl-CoA and 5-cis-tetradecenoyl-
CoA to LCAD was shown in a study [89]. This might explain the poorer oxidation and 
greater accumulation of intermediates of TFAs compared to those of oleate. 
The cis-unsaturated oleate has been repeatedly shown to reduce the damage 
caused by the saturated palmitate [81], so another goal of our investigation was to 
compare this ability to that of trans-unsaturated elaidate and vaccenate. The experimental 
parameters were the same as described above, while each of the unsaturated FAs were 
simultaneously administered with palmitate and at the same concentration. Regardless of 
the doubled FA dose, the cells were successfully rescued from cellular damage caused by 
palmitate after the co-treatment with oleate, as expected. The co-treatment with oleate 
protected the cells from lipoapoptosis and from stress, as shown by the lack of caspase-3 
cleavage, the phosphorylation of JNK, the cleavage of XBP-1 mRNA and 
phosphorylation of eIF2α, as two crucial parts of the UPR. The co-treatment with oleate 
significantly reduced the levels of those ceramides that contain saturated FA chains. This 
shows that oleate is able to mitigate the ceramide accumulation caused by palmitate. 
Similar effect was seen in the DG accumulation, as the overall DG level was lower, just 
like the level of DGs containing saturated chains although the incorporation of oleate in 
this case was much more noticeable. All things considered, the protective effect of oleate 
was evident in our experiments, and it is in agreement with the data found in the literature. 
The effect of TFA co-treatments were rather similar to that of oleate. One of the 
obvious differences was observed in the levels of phosphorylated JNK, which was not 
reduced as effectively, indicating remaining overall stress in the cells. Another interesting 
observation was that elaidate did not manage to attenuate the ER stress as successfully as 
the other two unsaturated FAs, but the viability and apoptosis analysis did not show such 
differences. Although the TFAs prevented the accumulation of ceramides containing 




explicit amount of unsaturated ceramides was detected after TFA co-treatment. The 
described reduction of ceramide levels corresponded well with decreased intensity of 
apoptosis. In the first 8 h of the incubation with FAs, a similar observation can be made 
in the DG content, but in later times, the total DG levels after TFA co-treatment 
approached the amounts observed in palmitate treatments. This phenomenon is partly 
caused by the increase in DGs containing TFA chains. Based on these observations, we 
believe that the accumulation of ceramides is an important step in the development of β-
cell lipotoxicity and lipoapoptosis. These results also indicate that TFAs are not the most 
harmful type of FAs, at least in concern with β-cells and diabetes. 
As previously alluded, the TG synthesis is a possible way for the cells to drain 
acyl-CoA surplus. Some studies suggest that the outstanding toxicity of saturated FAs is 
due to the inability of the cells to process fully saturated DGs [4]. Based on these 
observations some theories suggest that the ability of unsaturated FAs to mitigate 
palmitate toxicity is due to their help for the TG synthesis to proceed. These assumptions 
are supported by experimental data obtained in different cell types, such as CHO cells 
and primary mouse embryonic fibroblasts [4], mouse myoblasts [90], human 
mesenchymal stromal cells and osteoblasts [65]. On the other hand, palmitate treatment 
in HepG2 cells resulted in controversial data regarding the deleterious or protective role 
of TG deposition in β-cell lipotoxicity [64, 91, 92]. After the comparison of FA profiles, 
our data suggest, that this assumed mechanism might not play a central role in the 
protective effect of the investigated unsaturated FAs in RINm5F cells, since the 
incorporation of palmitate into the cells decreased after co-treatments. The observed 
difference was almost as much as the increase in the amount of unsaturated FAs. These 
findings suggest that the reduction in ceramide and DG accumulation can be attributed, 
at least partly, to a lower palmitate uptake in the co-treated cells. The possible interference 
between the cellular uptake of different FAs and/or the saturation of FA uptake in our 





The toxic effect of saturated FAs, such as palmitate, is widely accepted, and so is 
the advantage of mono- and polyunsaturated FAs. The ability of cis unsaturated FAs to 
attenuate palmitate toxicity was also described previously. However, neither the toxicity 
nor the possible protective effect of dietary TFAs was properly addressed and clarified. 
During our investigation, we wanted to deepen our knowledge, and to suggest some 
explanation on the contradictory in vivo data on the effects of elaidate and vaccenate. 
Based on our results, the conclusions are: 
- Compared to the two most studied endogenous FAs, the toxicity of the two major 
dietary TFAs (i.e., elaidate and vaccenate) was below that of saturated palmitate, but 
slightly above that of the unsaturated oleate.  
- All of the FAs were incorporated and metabolized by the cell; however, there is 
a significant difference between the metabolism of cis and trans unsaturated FAs as, 
unlike that of oleate, the products of the first step of β-oxidation of TFAs were obviously 
accumulated.  
- The accumulation of ceramides and DGs after the addition of any of the 
unsaturated FAs remained far below that induced by palmitate. The incorporation of 
oleate into ceramides was inconspicuous. Either of the investigated TFAs induced a 
ceramide and DG accumulation, which was significantly greater than that induced by 
oleate. These results strengthen the correlation between ceramide and DG accumulation 
and the intensity of cell damage. 
- The simultaneous addition of oleate with palmitate reduced the cellular damage 
caused by the latter. The co-treatment with TFAs exerted an almost similar protection 
against the deleterious effects of the saturated FA, nevertheless the phosphorylated JNK 
levels were slightly higher, indicating an elevated stress intensity in the cells, and the 
attenuation of ER stress by elaidate was weaker compared to the other two unsaturated 
FAs.  
- The presence of oleate reduced the amounts of ceramides and DGs containing 
saturated FAs chains remarkably in co-treatments. While the TFAs also reduced the 
ceramide and DGs levels in co-treatments, over the time, the DG levels reached a 




treatments. These data further support the role of ceramides in β-cell lipotoxicity and they 
also indicate an important difference between the metabolism of oleate and the TFAs. 
TFA consumption is not only related to diabetes, and its role is suspected also in 
cardiovascular diseases or other metabolic disorders. Because of this, other cell lines 
which are possibly targets of TFA toxicity should be investigated through similar 
experiments. We observed remarkable metabolic differences between TFAs and oleate. 
These effect were not reflected in the short-term toxicity, but considering the fact, that 
the consumption of dietary FAs is a long-term condition, these differences may have 





Permanently high free FA levels are deleterious to many cell types including the 
insulin producing pancreatic β-cells. This lipotoxicity is largely due to an increased 
intracellular acyl-CoA supply and the consequent accumulation of biosynthetic lipid 
intermediates, such as ceramides and diglycerides, which in turn causes ER stress and 
apoptosis. Toxicity of the saturated palmitate (16:0) exceeds that of cis-unsaturated oleate 
(18:1 cis-Δ9), moreover simultaneous addition of oleate can decrease the effect of 
palmitate. While the toxicity of and interaction between palmitate and oleate have been 
widely investigated, very little data is available on the cell damages caused by elaidate 
(18:1 trans-Δ9) and vaccenate (18:1 trans-Δ11), although the potential health effects of 
these dietary TFAs received great publicity. We aimed to compare the effects of these 
four FAs at high concentrations (250-500 μM) on cell viability, apoptosis, ER stress, JNK 
phosphorylation alone or in combination treatment, in RINm5F insulinoma cells. 
Changes in the overall FA profile and the ceramide and diglyceride contents of the cells 
were also determined by using GC-FID and LC-MS/MS analysis. We observed a marked 
toxicity of palmitate, which was attenuated by a simultaneous addition of oleate. In spite 
of their efficient uptake and incorporation in the cells, the two TFAs were found to be 
scarcely toxic in our experiments. Similarly to oleate and unlike palmitate, they reduced 
cell viability only at higher concentration, and their impact on ER stress, apoptosis and 
autophagy was not significant. Palmitate also caused a several fold increase in both 
ceramide and diglyceride levels, while much smaller elevations were induced by the 
unsaturated FAs, either cis or trans; however, the incorporation of TFAs in ceramides was 
strikingly more pronounced compared to oleate. These results show an obvious 
correlation between the severity of cell damage and the accumulation of lipid 
intermediates caused by different FA species. This pioneering study on cellular effects of 
TFAs does not support a short term toxicity of these dietary compounds in insulinoma 
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